Table 2.
Major criteria (must be present) |
Presence of exocrine pancreatic insufficiency (monoclonal fecal elas tase-1 test or direct function tests) |
Pathological pancreatic imaging (endoscopic ultrasound, MRI, CT) |
Absence of type 1 diabetes mellitus associated autoimmune markers |
Minor criteria |
Absent pancreatic polypeptide secretion |
Impaired incretin secretion (e.g., GLP-1) |
No excessive insulin resistance (e.g., HOMA-IR) |
Impaired beta cell function (e.g., HOMA-B, C-Peptide/glucose-ratio) |
Low serum levels of lipid soluble vitamins (A, D, E and K) |
MRI: Magnetic resonance imaging; CT: Computed tomography; GLP-1: Glucagon-like peptide-1; HOMA-IR: Homeostasis model assessment of insulin resistance; HOMA-B: Homeostasis model assessment of beta-cell.